NK cells and IL-15 in the human innate immune response to tuberculosis

NK 细胞和 IL-15 在人类对结核病的先天免疫反应中的作用

基本信息

  • 批准号:
    7293248
  • 负责人:
  • 金额:
    $ 19.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-14 至 2009-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Despite extensive exposure to M. tuberculosis over long periods, some persons remain tuberculin-negative, suggesting that innate immunity controls the infection before T cells recognize M. tuberculosis antigens. We have found that NK cells from healthy donors lyse M. tuberculosis-infected mononuclear phagocytes through binding of NKp46 and NKG2D on NK cells to vimentin and ULBP1, respectively, on infected cells. Our preliminary data indicate that, in tuberculin-negative persons with heavy exposure to tuberculosis (heavily exposed PPD-s), NK cells lyse more infected monocytes than NK cells from other healthy donors. Monocytes from heavily exposed PPD-s also produce high concentrations of IL-15. Based on these data, we hypothesize that: (1) NKp46, NKG2D and their ligands mediate the enhanced lytic capacity of NK cells from heavily exposed PPD-s; (2) NKp46, NKG2D and their ligands are upregulated by IL-15-mediated signaling. To address these hypotheses, we propose the following aims. Aim 1. Determine if NKp46, NKG2D and their ligands contribute to the increased capacity of NK cells from heavily exposed PPD-s to lyse M. tuberculosis-infected cells. 1.1. Surface expression and neutralization of NK cell receptors and ligands. We will measure expression of NKp46, NKG2D vimentin and ULBP1 by flow cytometry. We will use siRNA and neutralizing antibodies to these receptors and ligands to determine their contribution to lysis of infected cells. 1.2. Mechanisms for upregulation of NK cell receptors and ligands. We will determine if upregulated NK cell receptors and ligands in heavily exposed PPD-s show increased mRNA expression or increased translocation of protein to the cell surface. 1.3. Do heavily exposed PPD-s show greater NK cell lysis of cells infected with other pathogens? We will evaluate the capacity of NK cells from heavily exposed PPD-s to lyse cells infected with Listeria, Cryptosporidium and Epstein Barr virus. We will also measure expression of NK cell receptors and ligands found to be upregulated in aim 1.1. Aim 2. Determine the contribution of IL-15 to the capacity of NK cells from heavily exposed PPD-s to lyse infected cells. 2.1. Effects of IL-15 on expression of NKp46, NKG2D, vimentin and ULBP1. We will use antibodies to IL-15 and its receptor, as well as siRNA, to determine if IL-15 increases expression of NK cell receptors and ligands in heavily exposed PPD-s, and to determine if it does so through soluble cytokine or by binding to IL-15R and signaling in trans to NK cells. 2.2. To delineate the signaling pathways by which IL- 15 increases expression of NK cell receptors and ligands. We will evaluate expression of STAT3, STAT5 and STAT6 in NK cells and infected monocytes by Western blot. Next, we will use siRNA and lentiviral vectors to alter STAT levels, and identify the IL-15-induced STATs that increase expression of NK cell receptors and ligands. These studies will provide insight into innate mechanisms of resistance to tuberculosis, which will be critical for development of vaccines that maximize innate immune responses. Tuberculosis is an infectious disease that kills 1.9 million people worldwide annually, and development of an effective vaccine is an urgent public health priority. Some persons have innate resistance to tuberculosis and do not become infected despite extensive exposure to infectious tuberculosis patients. This proposal will provide new insight into the immunologic mechanisms for this increased resistance, and harnessing of these mechanisms will be critical to develop a vaccine that maximizes innate resistance to tuberculosis.
描述(由申请人提供):尽管广泛暴露于M。在长期的结核病中,有些人保持结核菌素阴性,这表明先天免疫在T细胞识别M之前控制感染。结核抗原我们已经发现,来自健康供体的NK细胞裂解M。通过NK细胞上的NKp 46和NKG 2D分别与感染细胞上的波形蛋白和ULBP 1结合,抑制结核病感染的单核吞噬细胞。我们的初步数据表明,在结核菌素阴性的人与结核病的严重暴露(严重暴露的PPD-s),NK细胞裂解更多的感染单核细胞比其他健康供体的NK细胞。来自高度暴露的PPD的单核细胞也产生高浓度的IL-15。基于这些数据,我们假设:(1)NKp 46、NKG 2D及其配体介导来自重度暴露的PPD-s的NK细胞的溶解能力增强;(2)NKp 46、NKG 2D及其配体通过IL-15介导的信号传导上调。为了解决这些假设,我们提出了以下目标。 目标1.确定NKp 46、NKG 2D及其配体是否有助于增加来自重度暴露PPD-s的NK细胞裂解M的能力。结核病感染细胞1.1. NK细胞受体和配体的表面表达和中和。我们将通过流式细胞术测量NKp 46、NKG 2D波形蛋白和ULBP 1的表达。我们将使用针对这些受体和配体的siRNA和中和抗体来确定它们对感染细胞裂解的贡献。1.2. NK细胞受体和配体的上调机制。我们将确定是否在大量暴露的PPD中上调的NK细胞受体和配体显示mRNA表达增加或蛋白质向细胞表面的易位增加。1.3.重度暴露的PPD是否显示出对感染其他病原体的细胞的更大的NK细胞溶解?我们将评估来自高度暴露的PPD的NK细胞裂解李斯特菌、隐孢子虫和爱泼斯坦巴尔病毒感染的细胞的能力。我们还将测量发现在目标1.1中上调的NK细胞受体和配体的表达。 目标2.确定IL-15对来自重度暴露的PPD-s的NK细胞裂解感染细胞的能力的贡献。2.1. IL-15对NKp 46、NKG 2D、波形蛋白和ULBP 1表达的影响。我们将使用针对IL-15及其受体的抗体以及siRNA来确定IL-15是否增加重度暴露的PPD中NK细胞受体和配体的表达,并确定其是否通过可溶性细胞因子或通过结合IL-15 R和反式信号传导至NK细胞来这样做。2.2.描述IL- 15增加NK细胞受体和配体表达的信号通路。我们将通过Western blot评估STAT 3、STAT 5和STAT 6在NK细胞和感染的单核细胞中的表达。接下来,我们将使用siRNA和慢病毒载体来改变STAT水平,并鉴定IL-15诱导的STAT,其增加NK细胞受体和配体的表达。这些研究将提供对结核病抗性的先天机制的深入了解,这对于开发最大化先天免疫应答的疫苗至关重要。 结核病是一种传染病,每年在全世界造成190万人死亡,开发有效的疫苗是一项紧迫的公共卫生优先事项。有些人对结核病具有先天抵抗力,即使广泛接触传染性结核病患者也不会受到感染。这一提议将为这种增加的抗性的免疫机制提供新的见解,并且利用这些机制对于开发最大化对结核病的先天抗性的疫苗至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter F. Barnes其他文献

Peter F. Barnes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter F. Barnes', 18)}}的其他基金

NK cells and IL-15 in the human innate immune response to tuberculosis
NK 细胞和 IL-15 在人类对结核病的先天免疫反应中的作用
  • 批准号:
    7496421
  • 财政年份:
    2007
  • 资助金额:
    $ 19.76万
  • 项目类别:
Regulation of IFN-gamma production in human tuberculosis
人类结核病中 IFN-γ 产生的调节
  • 批准号:
    7061248
  • 财政年份:
    2005
  • 资助金额:
    $ 19.76万
  • 项目类别:
Regulation of IFN-gamma production in human tuberculosis
人类结核病中 IFN-γ 产生的调节
  • 批准号:
    7369790
  • 财政年份:
    2005
  • 资助金额:
    $ 19.76万
  • 项目类别:
Regulation of IFN-gamma production in human tuberculosis
人类结核病中 IFN-γ 产生的调节
  • 批准号:
    7585171
  • 财政年份:
    2005
  • 资助金额:
    $ 19.76万
  • 项目类别:
Regulation of IFN-gamma production in human tuberculosis
人类结核病中 IFN-γ 产生的调节
  • 批准号:
    6983678
  • 财政年份:
    2005
  • 资助金额:
    $ 19.76万
  • 项目类别:
Regulation of IFN-gamma production in human tuberculosis
人类结核病中 IFN-γ 产生的调节
  • 批准号:
    7196490
  • 财政年份:
    2005
  • 资助金额:
    $ 19.76万
  • 项目类别:
TRANSMISSION DYNAMICS OF TB ALONG THE U.S.-MEXICO BORDER
结核病沿美国-墨西哥边境的传播动态
  • 批准号:
    6195653
  • 财政年份:
    2000
  • 资助金额:
    $ 19.76万
  • 项目类别:
TRANSMISSION DYNAMICS OF TB ALONG THE U.S.-MEXICO BORDER
结核病沿美国-墨西哥边境的传播动态
  • 批准号:
    6374095
  • 财政年份:
    2000
  • 资助金额:
    $ 19.76万
  • 项目类别:
TRANSMISSION DYNAMICS OF TB ALONG THE U.S.-MEXICO BORDER
结核病沿美国-墨西哥边境的传播动态
  • 批准号:
    6748135
  • 财政年份:
    2000
  • 资助金额:
    $ 19.76万
  • 项目类别:
TRANSMISSION DYNAMICS OF TB ALONG THE U.S.-MEXICO BORDER
结核病沿美国-墨西哥边境的传播动态
  • 批准号:
    6534141
  • 财政年份:
    2000
  • 资助金额:
    $ 19.76万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.76万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了